We're currently fundraising! Become an early investor in Bioverge to own an expanding portfolio of leading TechBio startups through a single investment 🔬! Learn more and invest today 💸!
C6jfl3hhtiohykcygh7t

Juno Diagnostics Investment

Juno Diagnostics, a San Diego based genetic diagnostics company in the Bioverge portfolio, just raised a $25 million Series A round led by Perceptive Xontogeny Venture Fund in May 2021.

continue reading >
Bkect61tqqoepbcvxb2j

The Bioverge Podcast: Managing the Challenges of Scaling Cell and Gene Therapies

Amy DuRoss, co-founder and CEO of Vineti, sits down with Neil to discuss how the company’s platform technology addresses the unique supply chain management challenges of cell and gene therapy companies.

continue reading >
Z5mgyn4bt4g9w2zxzfti

✨ New Investment Opportunity: Transforming Epilepsy Care 🙇

Invest in Eysz to accelerate personalized treatments with improved patient outcomes for 70M+ epilepsy patients worldwide.

continue reading >
Bgisqcw2rhk0ly0d5pcw

Congratulations, Echo!

Congratulations to our portfolio company Echo on their acquisition by CELLINK!

continue reading >
Dnjkkldatvo4y3unrdx5

2021 Mid-Year Portfolio Performance Review

We’ve been investing in our thesis of TechBio for five years, so let’s take a look at how we’re doing…

continue reading >
H6hpaywtr4eamelmqay0

Why I Founded Bioverge: My Mission to Democratize Healthcare Investment Opportunities

Watch our CEO, Neil Littman, share the story that inspired him to found Bioverge.

continue reading >
F7xqdtj7ssypvkwzlynj

The Bioverge Podcast: Advancing a Pipeline of Off-The-Shelf Cell Therapies

Brian Culley, CEO of Lineage Cell Therapeutics, sits down with Neil to discuss his company’s efforts to develop off-the-shelf cell therapies to treat degenerative retinal disease, spinal cord injury, and cancer.

continue reading >
Vxbajvltmmgvzykrrvsr

The Bioverge Podcast: Weighing the Strengths and Weakness of Various COVID-19 Vaccines

Craig Laferrière head of vaccine development for Novateur Ventures, joins Neil to discuss the relative strengths and weaknesses of the different COVID-19 vaccines in use and in development.

continue reading >
T3jw61mvsy6ey99mx10x

Investment Opportunity, You Can Now Invest In Bioverge!

The Bioverge Reg CF Offering is Officially Live 🎊 and Accepting Investments!

continue reading >
Fmxdkbstmaltvlwyzsng

Investing with Impact

Impact investing is both financially and socially rewarding, providing benefits to the individual investor and the world at large.

continue reading >
C6jfl3hhtiohykcygh7t
Startups

Juno Diagnostics Investment

Juno Diagnostics, a San Diego based genetic diagnostics company in the Bioverge portfolio, just raised a $25 million Series A round led by Perceptive Xontogeny Venture Fund in May 2021.

Continue Reading >
Bkect61tqqoepbcvxb2j
Media

The Bioverge Podcast: Managing the Challenges of Scaling Cell and Gene Therapies

Amy DuRoss, co-founder and CEO of Vineti, sits down with Neil to discuss how the company’s platform technology addresses the unique supply chain management challenges of cell and gene therapy companies.

Continue Reading >
Z5mgyn4bt4g9w2zxzfti
Health + Tech, Investing, Startups

✨ New Investment Opportunity: Transforming Epilepsy Care 🙇

Invest in Eysz to accelerate personalized treatments with improved patient outcomes for 70M+ epilepsy patients worldwide.

Continue Reading >
Bgisqcw2rhk0ly0d5pcw
Health + Tech, Investing, Startups

Congratulations, Echo!

Congratulations to our portfolio company Echo on their acquisition by CELLINK!

Continue Reading >
Dnjkkldatvo4y3unrdx5
Investing

2021 Mid-Year Portfolio Performance Review

We’ve been investing in our thesis of TechBio for five years, so let’s take a look at how we’re doing…

Continue Reading >
H6hpaywtr4eamelmqay0
Health + Tech, Investing, Media

Why I Founded Bioverge: My Mission to Democratize Healthcare Investment Opportunities

Watch our CEO, Neil Littman, share the story that inspired him to found Bioverge.

Continue Reading >
F7xqdtj7ssypvkwzlynj
Media

The Bioverge Podcast: Advancing a Pipeline of Off-The-Shelf Cell Therapies

Brian Culley, CEO of Lineage Cell Therapeutics, sits down with Neil to discuss his company’s efforts to develop off-the-shelf cell therapies to treat degenerative retinal disease, spinal cord injury, and cancer.

Continue Reading >
Vxbajvltmmgvzykrrvsr
Media

The Bioverge Podcast: Weighing the Strengths and Weakness of Various COVID-19 Vaccines

Craig Laferrière head of vaccine development for Novateur Ventures, joins Neil to discuss the relative strengths and weaknesses of the different COVID-19 vaccines in use and in development.

Continue Reading >
T3jw61mvsy6ey99mx10x
Health + Tech, Investing, Press

Investment Opportunity, You Can Now Invest In Bioverge!

The Bioverge Reg CF Offering is Officially Live 🎊 and Accepting Investments!

Continue Reading >
Fmxdkbstmaltvlwyzsng
Investing

Investing with Impact

Impact investing is both financially and socially rewarding, providing benefits to the individual investor and the world at large.

Continue Reading >
Prev Next